Risk of thromboembolism in cisplatin versus carboplatin-treated patients with lung cancer

INTRODUCTION: Carboplatin is widely used to treat lung cancer in the United States as an alternative to cisplatin. Several studies have demonstrated that cisplatin-based regimen is associated with a high frequency of thromboembolic complications. However, there has been limited investigation directl...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Eric S., Baran, Andrea M., Mondo, Esther L., Rodgers, Thomas D., Nielsen, Gradon C., Dougherty, David W., Pandya, Kishan J., Rich, David Q., van Wijngaarden, Edwin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5724847/
https://www.ncbi.nlm.nih.gov/pubmed/29228042
http://dx.doi.org/10.1371/journal.pone.0189410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5724847/
https://www.ncbi.nlm.nih.gov/pubmed/29228042
http://dx.doi.org/10.1371/journal.pone.0189410

Ejemplares similares